Trials / Terminated
TerminatedNCT02105623
EARly Prevention of aTHeroma Progression
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 111 (actual)
- Sponsor
- CHEOL WHAN LEE, M.D., Ph.D · Academic / Other
- Sex
- All
- Age
- 35 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare standard therapy (risk factor control, life style modification) versus standard therapy plus low-dose rosuvastatin therapy (5mg/day) on progression of coronary atherosclerosis in statin naive individuals who have mild CAD (nonobstructive coronary atherosclerotic plaques) and normal LDL (low-density lipoprotein) cholesterol levels(\<130mg/dl).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Standard Therapy | Risk factor control Diet Exercise for 24months |
| DRUG | Rosuvastatin | Risk factor control rosuvastatin 5mg/day for 24months |
Timeline
- Start date
- 2014-06-01
- Primary completion
- 2018-03-01
- Completion
- 2018-03-01
- First posted
- 2014-04-07
- Last updated
- 2018-06-25
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02105623. Inclusion in this directory is not an endorsement.